Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0UX4A
|
||||
| Former ID |
DIB001674
|
||||
| Drug Name |
HU-433
|
||||
| Synonyms |
CB2 activator (osteoporosis); HU-433; CB2 activator (osteoporosis), Yissum
|
||||
| Indication | Osteoporosis [ICD9: 733.0, V07.4; ICD10:M80-M81, Z79.890] | Investigative | [543878] | ||
| Company |
Yissum Research Development Co
|
||||
| Canonical SMILES |
c1(c(cc(cc1OC)C(CCCCCC)(C)C)OC)[C@@H]1C=C([C@H]2C(C)(C)<br />[C@@H]1C2)CO
|
||||
| Target and Pathway | |||||
| Target(s) | Cannabinoid receptor 2 | Target Info | Activator | [543878] | |
| KEGG Pathway | Neuroactive ligand-receptor interaction | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.